Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by fidrock1991on Jan 03, 2018 9:17am
72 Views
Post# 27269261

California legal

California legal

The Globe and Mail reports in its Wednesday edition that Canada can learn a lot from California's experience legalizing marijuana as we prepare for legalization July 1. The Globe's Andre Picard writes that while California's legalization has got a lot of media attention, the state has granted only 49 retail licences so far, and only six cities have allowed cannabis stores to operate while more than 300 have blocked non-medicinal sales. This is a reminder that municipalities can -- and will -- throw a wrench into plans for retail stores, despite federal and provincial laws. The price of legal marijuana is a big issue. California has imposed an excise tax of 15 per cent on legal cannabis, in addition to state and local sales taxes and cultivation taxes on producers. Practically, that means the in-store price (about $50, similar to street prices) of an eighth-ounce (3.5 grams) of top-quality product will reach $65 after taxes. Allowing existing outlets to expand beyond the medicinal market to the recreational one will give California a smoother transition to legalization. By contrast, some provinces, like Ontario, have declared war on dispensaries. Legislators need to allow the retail environment to meet consumer demand.

© 2018 Canjex Publishing Ltd.

Bullboard Posts